Louis Okeibunor Odeigah

Louis Okeibunor Odeigah

Auto-generated profile, based on publicly available information

Louis Okeibunor Odeigah

Department of Family Medicine, University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Cogent Medicine
Verified
Journal Article
Open access
SRShittu O. Rasaki
Shittu O. Rasaki
FKFakorede O. Kasali
Fakorede O. Kasali
SBSikiru A. Biliaminu
Sikiru A. Biliaminu
LOLouis O. Odeigah
Louis O. Odeigah
ASAderibigbe A. Sunday
Aderibigbe A. Sunday
YMYusuf Musah
Yusuf Musah

1 June 2017 in Alexandria Journal of Medicine
Verified
Journal Article
Open access
AFA.E. Fawibe
A.E. Fawibe
LOL.O. Odeigah
L.O. Odeigah
TAT.M. Akande
T.M. Akande
ASA.G. Salaudeen
A.G. Salaudeen
IOI. Olanrewaju
I. Olanrewaju
There is need for information on the medical care seeking behaviour of Nigerian doctors. This work was therefore designed to study the medical care seeking behaviour of Nigerian doctors in Nigeria. It was a cross-sectional survey among doctors in Nigeria. Data from 522 doctors were included in the analysis. Majority of them (80.5%) had one form of illness or the other in the year preceding the survey. Only 35% of them reportedly consulted another doctor during their illness. Most of the consultations (61.2%) were informal in the form of over the phone (45.6%), Corridor (33.3%) and home visit (21.1%) and just 18.4% of the consultations occurred within 24 h of onset of illness. A low 19.5% of them had a regular source of medical care. Screening for illnesses was generally below expectation. Just 6 out of the 436 (1.4%) male doctors had screened for prostate cancer while 39 out of 86 (45.3%) females had screened for cervical cancer. A significantly higher proportion of general practitioners (p = 0.01) and doctors above 45 years of age (P = 0.004) consulted informally. Higher proportion of general practitioners and resident doctors based their consultations on their familiarity with the doctors consulted (p = 0.001) and privacy during consultation (p = 0.001). Delay in consultation for more than 24 h after onset of illness was more likely in those above below the age of 45 years (p = 0.001). This study has shown that Nigerian doctors are often reluctant patients who frequently tend to delay medical care. The teaching of appropriate medical care seeking behaviour should be incorporated into medical curriculum in Nigeria.

15 August 2022 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
LOLouis Okeibunor Odeigah
Louis Okeibunor Odeigah
YMYAHKUB BABATUNDE MUTALUB
YAHKUB BABATUNDE MUTALUB
OAOlalekan Ayodele Agede
Olalekan Ayodele Agede
IOIsmail A. Obalowu
Ismail A. Obalowu
SASusan Aiyetoro
Susan Aiyetoro
GJGafar A. A. Jimoh
Gafar A. A. Jimoh
Safe and effective vaccination remains the mainstay of control of COVID-19 because there is still no universally recommended treatment. This strategy is however being threatened by vaccine hesitancy and resistance due to fear of adverse events and safety concerns. It is, therefore, necessary to study post-vaccination adverse events (AE) in various populations and geographical areas. The objective of this study was to analyze the adverse events following COVID-19 vaccination in five major immunization centers of Kwara State Nigeria. A retrospective descriptive study of the adverse events following AstraZeneca COVID-19 vaccination that were reported from five immunization centers of Kwara State, North-central Nigeria from March to July 2021 was carried out. Statistical Package for Social Science version 26 was used for analysis. Adverse event classification and severity were compared based on age, gender, and time to onset of adverse event and vaccine dose type using the Chi-square test. The incidence of COVID-19 vaccine AE was 1.6%. There was female predominance (51.6%) and a mean age of 41.6±13.7 years. Most of the AE (95.8%) were systemic and mild (81.1%) without a requirement for any therapeutic intervention. Fatal outcome was not reported in any of the AE and the time to outcome of AE was 2 days in most cases (45.3%). No significant association was found between the variables studied and the adverse event type and severity. The low incidence and mild nature of adverse events reported in this study will add to the body of knowledge regarding vaccine adverse events and may eventually impact vaccine uptake.